Cargando…
Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box?
Background: Coronavirus 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with severe hypercoagulable conditions and complex venous thrombosis is common. Several recent studies have reported elevated aPTT in COVID-19 patients with a...
Autores principales: | Kim, Hyunji, Jang, Seongsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701509/ http://dx.doi.org/10.1182/blood-2021-150073 |
Ejemplares similares
-
Study of Coagulopathies in Covid 19 Positive Patients & Their Correlation with Outcome of Disease
por: Khunger, Jitender, et al.
Publicado: (2020) -
VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020) -
COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting
por: Gadde, Saikrishna, et al.
Publicado: (2020) -
Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease
por: Thomas, Mari, et al.
Publicado: (2020) -
Venous Thromboembolic Disease in Children Associated with COVID-19
por: Narang, Shalu, et al.
Publicado: (2020)